Dna analysis for germline mutations of the ret proto-oncogene for susceptibility to multiple endocrine neoplasia type 2

S3840
HCPCS Code

2023 HCPCS
Billable/Valid Code

S3840 is a valid 2023 HCPCS Code that could be used to indicate Dna analysis for germline mutations of the ret proto-oncogene for susceptibility to multiple endocrine neoplasia type 2 for reimbursement purposes.

S3840 belongs to Other Medical Items or Services Type of Service and has been in effect since Jul 01, 2003.

Short description for S3840 HCPCS code:

Dna analysis ret-oncogene

HCPCS S3840

S3840 code information

HCPCS code:	S3840
Description:	DNA ANALYSIS FOR GERMLINE MUTATIONS OF THE RET PROTO-ONCOGENE FOR SUSCEPTIBILITY TO MULTIPLE ENDOCRINE NEOPLASIA TYPE 2
Effective Date:	Jul 01, 2003
Added Date:	Jul 01, 2003
Termination Date:	HCPCS S3840 was terminated on Nov 30, -0001
Pricing indicator:	`00` - SERVICE NOT SEPARATELY PRICED BY PART B (E.G., SERVICES NOT COVERED, BUNDLED, USED BY PART A ONLY, ETC.) PHYSICIAN FEE SCHEDULE AND NON-PHYSICIAN PRACTITIONERS
Multi Pricing indicator:	`9` - NOT APPLICABLE AS HCPCS NOT PRICED SEPARATELY BY PART B (PRICING INDICATOR IS 00) OR VALUE IS NOT ESTABLISHED (PRICING INDICATOR IS ´99´)
Coverage code:	`I` - NOT VALID FOR MEDICARE (NO GRACE PERIOD)
BETOS code:	`Z2` - UNDEFINED CODES
Action code:	`N` - NO MAINTENANCE FOR THIS CODE
Type of Service:	`9` - OTHER MEDICAL ITEMS OR SERVICES
Anesthesia BUQ:	0